Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, PR China.
Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, PR China.
Life Sci. 2020 Apr 1;246:117415. doi: 10.1016/j.lfs.2020.117415. Epub 2020 Feb 6.
High-mobility group box 1 protein (HMGB1) is a crucial proinflammatory cytokine that contributes to acute lung injury (ALI). Macrophages are known to express the primary receptors (Toll-like receptor [TLR] 2, and TLR4) of HMGB1 for transmitting intracellular signals. Studies have revealed that double-stranded RNA activated protein kinase R (PKR), which is expressed in macrophages, participates in ALI by regulating macrophage polarization and proinflammatory cytokine release, and that PKR is normally activated by a subset of TLRs. The present study investigated whether HMGB1 engages in ALI by activating PKR in macrophages and inducing classically activated macrophage (M1) polarization via TLR2- and TLR4-mediated nuclear factor (NF)-κB signaling pathways. In an vivo mouse model of lipopolysaccharide (LPS)-induced ALI, anti-HMGB1, rHMGB1, LPS-RS (TLR2 and TLR4 antagonist), or C16 (PKR inhibitor) was administered to mice 2 h after LPS challenge or 1 h before LPS challenge. In vitro, bone marrow-derived macrophages from mice primed with LPS were stimulated with or without anti-HMGB1, rHMGB1, LPS-RS, or C16. Our studies revealed that rHMGB1 stimulation induced M1 polarization in ALI, and that anti-HMGB1 and C16 treatments had the opposite effect. Anti-HMGB1 and LPS-RS significantly inhibited LPS-induced PKR expression in macrophages; however, rHMGB1 administration increased PKR expression. These results indicate that HMGB1 participates in the pathogenesis of ALI by activating PKR in macrophages and inducing M1 polarization through TLR2- and TLR4-mediated NF-κB signaling pathways.
高迁移率族蛋白 B1(HMGB1)是一种关键的促炎细胞因子,有助于急性肺损伤(ALI)。已知巨噬细胞表达 HMGB1 的主要受体(Toll 样受体 [TLR] 2 和 TLR4),用于传递细胞内信号。研究表明,双链 RNA 激活蛋白激酶 R(PKR)在巨噬细胞中表达,通过调节巨噬细胞极化和促炎细胞因子释放参与 ALI,PKR 通常被一组 TLR 激活。本研究探讨了 HMGB1 是否通过在巨噬细胞中激活 PKR 并通过 TLR2 和 TLR4 介导的核因子(NF)-κB 信号通路诱导经典激活的巨噬细胞(M1)极化来参与 ALI。在脂多糖(LPS)诱导的 ALI 小鼠模型中,在 LPS 挑战后 2 小时或 LPS 挑战前 1 小时给予抗 HMGB1、rHMGB1、LPS-RS(TLR2 和 TLR4 拮抗剂)或 C16(PKR 抑制剂)。在体外,用 LPS 预刺激的骨髓来源的巨噬细胞用或不用抗 HMGB1、rHMGB1、LPS-RS 或 C16 刺激。我们的研究表明,rHMGB1 刺激诱导 ALI 中的 M1 极化,而抗 HMGB1 和 C16 处理则产生相反的效果。抗 HMGB1 和 LPS-RS 显著抑制 LPS 诱导的巨噬细胞中 PKR 的表达;然而,rHMGB1 给药增加了 PKR 的表达。这些结果表明,HMGB1 通过在巨噬细胞中激活 PKR 并通过 TLR2 和 TLR4 介导的 NF-κB 信号通路诱导 M1 极化参与 ALI 的发病机制。